Latest Headlines
-
Nucleai And GoPath Diagnostics Announce Strategic Collaboration To Provide Integrated AI-Powered Digital Pathology Solutions For Clinical Research And Diagnostic Applications
4/8/2024
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration with GoPath Diagnostics, a leading full-service digital pathology and molecular diagnostics laboratory.
-
Sebia Receives U.S. FDA Clearance For The CAPILLARYS 3 DBS Devices
4/5/2024
Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for CAPILLARYS 3 DBS devices.
-
Predicine Introduces PredicineCARE™ NGS Kit For Global Clinical Trials, CDx Development And Patient Testing
4/5/2024
Predicine, Inc., a leading molecular insights company, announced the release of its innovative PredicineCARE™ NGS Kit.
-
SOPHiA GENETICS And Strand Life Sciences Announce New Strategic Partnership
4/4/2024
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a strategic partnership with Strand Life Sciences, a pioneer in bioinformatics and diagnostics, to deliver innovative solutions that will fuel the use of precision medicine globally.
-
INTERACT Coalition Formed To Advance Patient Access To Genetic Testing For Hereditary Cancer Risk
4/3/2024
Leading commercial organizations and patient advocacy groups in the field of cancer genetics today announced the founding of the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), a coalition whose mission is to increase evidence-based access to genetic testing for people with or at risk of hereditary cancers.
-
Cepheid Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test
4/3/2024
Cepheid today announced that Xpert® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification list signifies that Xpert HIV-1 Qual XC meets WHO's stringent performance, quality, safety and reliability standards.
-
Descartes Labs Accelerates Growth With Strategic Acquisition Of Geosite
4/2/2024
Descartes Labs, a leading provider of geospatial analytics and artificial intelligence solutions, announced today that it acquired all of the operating assets of Geosite, a SaaS provider of geospatial intelligence to property and casualty insurance companies.
-
Quest Diagnostics And Broad Clinical Labs To Evaluate Whole Genome Sequencing As First-Line Genetic Test For Developmental Delay
4/2/2024
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and Broad Clinical Labs, the world expert in whole genome sequencing (WGS), today announced a research collaboration designed to demonstrate the clinical value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
-
Agilent Launches New Advanced Dilution System To Increase Lab Efficiency
4/1/2024
Agilent Technologies Inc. today announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.
-
Grace Health Technology Launches New Laboratory Management Software
3/29/2024
Grace Health Technology, a leading provider of innovative software solutions for the healthcare industry, today announced the expansion of its laboratory-specific applications with the launch of a groundbreaking new application poised to revolutionize laboratory technology and enhance efficiency in healthcare settings.